Annual CFF:
-$48.92M+$38.60M(+44.10%)Summary
- As of today, AMED annual cash from financing is -$48.92 million, with the most recent change of +$38.60 million (+44.10%) on December 31, 2024.
- During the last 3 years, AMED annual cash from financing has fallen by -$104.05 million (-188.75%).
Performance
AMED Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly CFF:
-$13.37M-$68.00K(-0.51%)Summary
- As of today, AMED quarterly cash from financing is -$13.37 million, with the most recent change of -$68.00 thousand (-0.51%) on June 30, 2025.
- Over the past year, AMED quarterly cash from financing has increased by +$859.00 thousand (+6.04%).
Performance
AMED Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CFF:
-$53.26M+$859.00K(+1.59%)Summary
- As of today, AMED TTM cash from financing is -$53.26 million, with the most recent change of +$859.00 thousand (+1.59%) on June 30, 2025.
- Over the past year, AMED TTM cash from financing has dropped by -$7.96 million (-17.58%).
Performance
AMED TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMED Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +44.1% | +6.0% | -17.6% |
3Y3 Years | -188.8% | -230.4% | -135.3% |
5Y5 Years | -121.5% | -116.3% | -163.9% |
AMED Cash From Financing Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -188.7% | +44.1% | -88.0% | +76.2% | -34.0% | +44.7% |
5Y | 5-Year | -121.5% | +44.1% | -105.6% | +90.9% | -135.3% | +84.8% |
All-Time | All-Time | -116.2% | +81.7% | -103.5% | +90.9% | -113.7% | +84.8% |
AMED Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$13.37M(-0.5%) | -$53.26M(+1.6%) |
Mar 2025 | - | -$13.30M(-15.6%) | -$54.12M(-5.8%) |
Dec 2024 | -$48.92M(+44.1%) | -$11.51M(+23.7%) | -$51.13M(+4.0%) |
Sep 2024 | - | -$15.09M(-6.0%) | -$53.27M(-17.6%) |
Jun 2024 | - | -$14.23M(-37.9%) | -$45.30M(-6.8%) |
Mar 2024 | - | -$10.31M(+24.4%) | -$42.40M(+51.9%) |
Dec 2023 | -$87.52M(-187.6%) | -$13.64M(-91.9%) | -$88.17M(+6.3%) |
Sep 2023 | - | -$7.11M(+37.2%) | -$94.15M(+1.6%) |
Jun 2023 | - | -$11.33M(+79.8%) | -$95.72M(-8.2%) |
Mar 2023 | - | -$56.09M(-185.9%) | -$88.44M(-122.5%) |
Dec 2022 | -$30.43M(-155.2%) | -$19.62M(-126.0%) | -$39.75M(+58.7%) |
Sep 2022 | - | -$8.68M(-114.6%) | -$96.32M(-163.9%) |
Jun 2022 | - | -$4.05M(+45.3%) | $150.72M(+43.6%) |
Mar 2022 | - | -$7.40M(+90.3%) | $104.93M(+91.2%) |
Dec 2021 | $55.13M(+468.1%) | -$76.19M(-132.0%) | $54.88M(+58.5%) |
Sep 2021 | - | $238.36M(+578.3%) | $34.62M(+109.9%) |
Jun 2021 | - | -$49.83M(+13.3%) | -$350.47M(-60.4%) |
Mar 2021 | - | -$57.46M(+40.4%) | -$218.48M(-1358.8%) |
Dec 2020 | -$14.98M(-106.6%) | -$96.44M(+34.3%) | -$14.98M(-118.0%) |
Sep 2020 | - | -$146.74M(-278.6%) | $83.36M(-56.8%) |
Jun 2020 | - | $82.16M(-43.7%) | $193.10M(+160.7%) |
Mar 2020 | - | $146.04M(+7590.5%) | $74.07M(-67.4%) |
Dec 2019 | $227.21M(+185.0%) | $1.90M(+105.1%) | $227.21M(+28.3%) |
Sep 2019 | - | -$37.00M(-0.3%) | $177.07M(+25.5%) |
Jun 2019 | - | -$36.87M(-112.3%) | $141.11M(+301.1%) |
Mar 2019 | - | $299.18M(+720.2%) | $35.18M(+113.2%) |
Dec 2018 | -$267.42M(-4728.9%) | -$48.24M(+33.9%) | -$267.42M(-21.6%) |
Sep 2018 | - | -$72.96M(+48.9%) | -$219.99M(-47.8%) |
Jun 2018 | - | -$142.80M(-4063.1%) | -$148.84M(-1718.9%) |
Mar 2018 | - | -$3.43M(-322.9%) | -$8.18M(-47.8%) |
Dec 2017 | -$5.54M(+26.3%) | -$811.00K(+55.0%) | -$5.54M(-3.4%) |
Sep 2017 | - | -$1.80M(+15.9%) | -$5.36M(-42.4%) |
Jun 2017 | - | -$2.14M(-172.7%) | -$3.76M(+64.3%) |
Mar 2017 | - | -$785.00K(-24.6%) | -$10.53M(-40.1%) |
Dec 2016 | -$7.51M(+64.0%) | -$630.00K(-204.3%) | -$7.51M(+15.7%) |
Sep 2016 | - | -$207.00K(+97.7%) | -$8.92M(-18.5%) |
Jun 2016 | - | -$8.91M(-499.2%) | -$7.53M(-458.7%) |
Mar 2016 | - | $2.23M(+209.9%) | -$1.35M(+93.6%) |
Dec 2015 | -$20.89M(-129.6%) | -$2.03M(-271.7%) | -$20.89M(-32.0%) |
Sep 2015 | - | $1.18M(+143.3%) | -$15.83M(+67.2%) |
Jun 2015 | - | -$2.73M(+84.2%) | -$48.27M(-185.5%) |
Mar 2015 | - | -$17.32M(-670.9%) | $56.45M(-20.0%) |
Dec 2014 | $70.56M(+233.0%) | $3.03M(+109.7%) | $70.56M(+61.1%) |
Sep 2014 | - | -$31.25M(-130.6%) | $43.81M(-39.1%) |
Jun 2014 | - | $101.99M(+3286.1%) | $71.93M(+317.1%) |
Mar 2014 | - | -$3.20M(+86.5%) | -$33.13M(+37.5%) |
Dec 2013 | -$53.05M(-23.5%) | -$23.72M(-656.4%) | -$53.05M(-13.5%) |
Sep 2013 | - | -$3.14M(-2.0%) | -$46.73M(+8.7%) |
Jun 2013 | - | -$3.07M(+86.7%) | -$51.21M(+11.0%) |
Mar 2013 | - | -$23.11M(-32.8%) | -$57.54M(-33.9%) |
Dec 2012 | -$42.96M(-31.0%) | -$17.41M(-128.6%) | -$42.96M(-32.9%) |
Sep 2012 | - | -$7.62M(+19.0%) | -$32.33M(+5.0%) |
Jun 2012 | - | -$9.40M(-10.2%) | -$34.04M(-0.9%) |
Mar 2012 | - | -$8.53M(-25.8%) | -$33.74M(-1.5%) |
Dec 2011 | -$32.79M(+30.0%) | -$6.78M(+27.3%) | -$33.24M(+7.4%) |
Sep 2011 | - | -$9.32M(-2.4%) | -$35.91M(+24.8%) |
Jun 2011 | - | -$9.11M(-13.3%) | -$47.78M(-4.5%) |
Mar 2011 | - | -$8.04M(+15.0%) | -$45.71M(+2.4%) |
Dec 2010 | -$46.85M(+60.6%) | -$9.45M(+55.4%) | -$46.85M(-5.7%) |
Sep 2010 | - | -$21.19M(-201.4%) | -$44.32M(-0.3%) |
Jun 2010 | - | -$7.03M(+23.4%) | -$44.21M(+60.3%) |
Mar 2010 | - | -$9.18M(-32.4%) | -$111.32M(+6.3%) |
Dec 2009 | -$118.77M | -$6.93M(+67.1%) | -$118.77M(+16.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2009 | - | -$21.08M(+71.6%) | -$141.75M(-3.5%) |
Jun 2009 | - | -$74.14M(-346.2%) | -$136.93M(-36.6%) |
Mar 2009 | - | -$16.62M(+44.4%) | -$100.26M(-133.2%) |
Dec 2008 | $301.57M(+9300.5%) | -$29.91M(-84.0%) | $301.57M(-9.3%) |
Sep 2008 | - | -$16.25M(+56.6%) | $332.54M(-4.6%) |
Jun 2008 | - | -$37.48M(-109.7%) | $348.74M(-10.0%) |
Mar 2008 | - | $385.21M(>+9900.0%) | $387.46M(>+9900.0%) |
Dec 2007 | $3.21M(-95.5%) | $1.06M(+2130.8%) | $3.21M(-95.8%) |
Sep 2007 | - | -$52.00K(-104.2%) | $77.20M(+0.4%) |
Jun 2007 | - | $1.25M(+30.3%) | $76.93M(+17.5%) |
Mar 2007 | - | $957.00K(-98.7%) | $65.47M(-9.0%) |
Dec 2006 | $71.97M(+47.7%) | $75.05M(>+9900.0%) | $71.97M(+656.0%) |
Sep 2006 | - | -$326.00K(+96.8%) | -$12.95M(-128.3%) |
Jun 2006 | - | -$10.22M(-236.9%) | $45.68M(-19.0%) |
Mar 2006 | - | $7.46M(+175.7%) | $56.42M(+15.8%) |
Dec 2005 | $48.71M(-25.8%) | -$9.86M(-116.9%) | $48.71M(-13.9%) |
Sep 2005 | - | $58.30M(>+9900.0%) | $56.58M(-15.5%) |
Jun 2005 | - | $518.00K(+312.3%) | $66.92M(+1.6%) |
Mar 2005 | - | -$244.00K(+87.8%) | $65.85M(+0.2%) |
Dec 2004 | $65.69M(+473.4%) | -$2.00M(-102.9%) | $65.69M(-20.8%) |
Sep 2004 | - | $68.64M(>+9900.0%) | $82.91M(+488.9%) |
Jun 2004 | - | -$545.00K(-33.9%) | $14.08M(+11.3%) |
Mar 2004 | - | -$407.00K(-102.7%) | $12.65M(+10.5%) |
Dec 2003 | $11.46M(+234.0%) | $15.22M(+8029.2%) | $11.46M(+236.8%) |
Sep 2003 | - | -$192.00K(+90.3%) | -$8.38M(-6.1%) |
Jun 2003 | - | -$1.97M(-22.7%) | -$7.89M(-1681.7%) |
Mar 2003 | - | -$1.60M(+65.2%) | -$443.00K(+93.1%) |
Dec 2002 | -$8.55M(-179.4%) | -$4.61M(-1683.8%) | -$6.45M(-320.9%) |
Sep 2002 | - | $291.00K(-94.7%) | $2.92M(+30.9%) |
Jun 2002 | - | $5.48M(+172.0%) | $2.23M(+134.5%) |
Mar 2002 | - | -$7.62M(-259.8%) | -$6.48M(-239.0%) |
Dec 2001 | $10.78M(+231.7%) | $4.77M(+1294.7%) | $4.66M(+159.6%) |
Sep 2001 | - | -$399.00K(+87.6%) | -$7.81M(+4.8%) |
Jun 2001 | - | -$3.23M(-191.7%) | -$8.21M(-190.6%) |
Mar 2001 | - | $3.52M(+145.7%) | -$2.82M(+65.5%) |
Dec 2000 | -$8.18M(-174.6%) | -$7.70M(-872.7%) | -$8.18M(-352.5%) |
Sep 2000 | - | -$792.00K(-136.8%) | $3.24M(+157.3%) |
Jun 2000 | - | $2.15M(+217.1%) | -$5.66M(-528.3%) |
Mar 2000 | - | -$1.84M(-149.5%) | -$900.00K(-108.2%) |
Dec 1999 | $10.96M(+250.2%) | $3.72M(+138.4%) | $10.96M(+205.7%) |
Sep 1999 | - | -$9.69M(-240.2%) | -$10.37M(-297.3%) |
Jun 1999 | - | $6.91M(-31.1%) | $5.26M(+206.0%) |
Mar 1999 | - | $10.02M(+156.9%) | $1.72M(+121.3%) |
Dec 1998 | -$7.30M(-236.5%) | -$17.61M(-396.5%) | -$8.05M(-160.9%) |
Sep 1998 | - | $5.94M(+76.3%) | $13.21M(+84.2%) |
Jun 1998 | - | $3.37M(+1232.0%) | $7.17M(+55.8%) |
Mar 1998 | - | $253.00K(-93.1%) | $4.60M(-14.0%) |
Dec 1997 | $5.35M(+37.8%) | $3.65M(+3749.0%) | $5.35M(+53.6%) |
Sep 1997 | - | -$100.00K(-112.5%) | $3.48M(-5.4%) |
Jun 1997 | - | $800.00K(-20.0%) | $3.68M(-7.5%) |
Mar 1997 | - | $1.00M(-43.9%) | $3.98M(+2.6%) |
Dec 1996 | $3.88M(+1070.5%) | $1.78M(+1682.0%) | $3.88M(+21.3%) |
Sep 1996 | - | $100.00K(-90.9%) | $3.20M(+39.1%) |
Jun 1996 | - | $1.10M(+22.2%) | $2.30M(+283.3%) |
Mar 1996 | - | $900.00K(-18.2%) | $600.00K(+250.0%) |
Dec 1995 | -$400.00K(-130.8%) | $1.10M(+237.5%) | -$400.00K(+73.3%) |
Sep 1995 | - | -$800.00K(-33.3%) | -$1.50M(-114.3%) |
Jun 1995 | - | -$600.00K(-500.0%) | -$700.00K(>-9900.0%) |
Mar 1995 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
Dec 1994 | $1.30M(0.0%) | - | - |
Jun 1994 | - | $100.00K(-80.0%) | $600.00K(+20.0%) |
Mar 1994 | - | $500.00K | $500.00K |
Dec 1993 | $1.30M | - | - |
FAQ
- What is Amedisys, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Amedisys, Inc.?
- What is Amedisys, Inc. annual cash from financing year-on-year change?
- What is Amedisys, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Amedisys, Inc.?
- What is Amedisys, Inc. quarterly cash from financing year-on-year change?
- What is Amedisys, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Amedisys, Inc.?
- What is Amedisys, Inc. TTM cash from financing year-on-year change?
What is Amedisys, Inc. annual cash from financing?
The current annual cash from financing of AMED is -$48.92M
What is the all-time high annual cash from financing for Amedisys, Inc.?
Amedisys, Inc. all-time high annual cash from financing is $301.57M
What is Amedisys, Inc. annual cash from financing year-on-year change?
Over the past year, AMED annual cash from financing has changed by +$38.60M (+44.10%)
What is Amedisys, Inc. quarterly cash from financing?
The current quarterly cash from financing of AMED is -$13.37M
What is the all-time high quarterly cash from financing for Amedisys, Inc.?
Amedisys, Inc. all-time high quarterly cash from financing is $385.21M
What is Amedisys, Inc. quarterly cash from financing year-on-year change?
Over the past year, AMED quarterly cash from financing has changed by +$859.00K (+6.04%)
What is Amedisys, Inc. TTM cash from financing?
The current TTM cash from financing of AMED is -$53.26M
What is the all-time high TTM cash from financing for Amedisys, Inc.?
Amedisys, Inc. all-time high TTM cash from financing is $387.46M
What is Amedisys, Inc. TTM cash from financing year-on-year change?
Over the past year, AMED TTM cash from financing has changed by -$7.96M (-17.58%)